Under the guidance of the Outline of Biotechnology R&D and Industrialization Development issued by the Ministry of Science and Technology and the National Development and Reform Commission, the Tumor Biotherapy Center took the lead in introducing international advanced CLS biotechnology, purchasing a large number of cutting-edge instruments and equipment, establishing a national GMP standard laboratory, and optimizing and reorganizing resources to build the first biotherapy center in Henan.
The Center has successively cooperated with Temple University, peking university health science center Biological Laboratory, Shanghai Academy of Life Sciences, National CLS Research Group and Clayson Tumor Biology Clinical Research Foundation of Chinese Medical Association, and has carried out technical exchanges with many units. It has successively become a biotechnology exchange unit of Renji Hospital affiliated to Shanghai Jiaotong University and a biotechnology exchange base in China and the United States.
The center is committed to the research and application of tumor cell immunotherapy technology, with the aim of "treating your own diseases with your own cells", taking "scientifically saving patients' lives" as its own responsibility, and always adhering to the service aim of "sincerely caring for patients". Free clinic activities free of registration fees and examination fees are carried out throughout the year, with one-stop service, accompanying examination, accompanying service and health consultation hotline for patients, which is well received by the majority of patients.